These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15199356)

  • 1. Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.
    Alsheikh-Ali AA; Wang PJ; Rand W; Konstam MA; Homoud MK; Link MS; Estes NA; Salem DN; Al-Ahmad AM
    Am Heart J; 2004 Jun; 147(6):1061-5. PubMed ID: 15199356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
    Vermes E; Tardif JC; Bourassa MG; Racine N; Levesque S; White M; Guerra PG; Ducharme A
    Circulation; 2003 Jun; 107(23):2926-31. PubMed ID: 12771010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
    Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG
    Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials.
    de Denus S; Tardif JC; White M; Bourassa MG; Racine N; Levesque S; Ducharme A
    Am Heart J; 2006 Oct; 152(4):705-12. PubMed ID: 16996842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.
    Salehian O; Healey J; Stambler B; Alnemer K; Almerri K; Grover J; Bata I; Mann J; Matthew J; Pogue J; Yusuf S; Dagenais G; Lonn E;
    Am Heart J; 2007 Sep; 154(3):448-53. PubMed ID: 17719288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
    Parker AB; Yusuf S; Naylor CD
    Am Heart J; 2002 Dec; 144(6):941-7. PubMed ID: 12486418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years.
    Buch P; Rasmussen S; Abildstrom SZ; Køber L; Carlsen J; Torp-Pedersen C;
    Eur Heart J; 2005 Jan; 26(2):145-52. PubMed ID: 15618070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost effectiveness of ACE inhibition in therapy of chronic heart failure in Switzerland: evaluation based on the SOLVD study].
    Szucs TD; Goedde M; Berger K; Kiowski W
    Schweiz Med Wochenschr; 1997 Jul; 127(29-30):1234-41. PubMed ID: 9333933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.
    Lemola K; Khan R; Nattel S; Talajic M; Roy D; Guerra PG; Lemola S; Dubuc M; Thibault B; Macle L; Khairy P
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):99-105. PubMed ID: 19140919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
    Ho SF; O'Mahony MS; Steward JA; Burr ML; Buchalter M
    Age Ageing; 2004 Sep; 33(5):488-92. PubMed ID: 15271642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction.
    Ishani A; Weinhandl E; Zhao Z; Gilbertson DT; Collins AJ; Yusuf S; Herzog CA
    J Am Coll Cardiol; 2005 Feb; 45(3):391-9. PubMed ID: 15680718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C; Cosentino E; De Sanctis D
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.
    Böhm M; Pogue J; Kindermann I; Pöss J; Koon T; Yusuf S
    Eur J Heart Fail; 2014 Mar; 16(3):325-33. PubMed ID: 24464788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
    Willenheimer R; van Veldhuisen DJ; Silke B; Erdmann E; Follath F; Krum H; Ponikowski P; Skene A; van de Ven L; Verkenne P; Lechat P;
    Circulation; 2005 Oct; 112(16):2426-35. PubMed ID: 16143696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic impact of the reduced incidence of atrial fibrillation in patients with heart failure treated with enalapril.
    Wagner M; Rindress D; Desjardins B; Meilleur MC; Ducharme A; Tardif JC
    Am Heart J; 2005 Nov; 150(5):985. PubMed ID: 16290980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
    Lévy S
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):220-5. PubMed ID: 16568131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R;
    Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the incidence of imidapril and enalapril induced cough.
    Boonyapisit W; Tresukosol D
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S48-53. PubMed ID: 20364557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular function and response to enalapril in patients with duchenne muscular dystrophy during the second decade of life.
    Ramaciotti C; Heistein LC; Coursey M; Lemler MS; Eapen RS; Iannaccone ST; Scott WA
    Am J Cardiol; 2006 Sep; 98(6):825-7. PubMed ID: 16950195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.